EW vs NVEC · P/E 47, rev $1.39B vs P/E 35, rev $25.9M
Edwards Lifesciences Corp (EW) versus NVE Corporation (NVEC) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
NVE Corporation (NVEC) is a semiconductors company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NVEC revenue for 2025-03-31 was $25.9M. Net income was $15.1M. Revenue was down 13.2% from 2024-03-31 to 2025-03-31. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NVEC currently screens at market cap $527.6M and trailing P/E 34.7.
Not investment advice. Open the EW and NVEC stock pages for the full models.
Not investment advice.